| scholarly article | Q13442814 |
| P356 | DOI | 10.12688/F1000RESEARCH.14556.1 |
| 10.12688/F1000RESEARCH.14556.3 | ||
| P932 | PMC publication ID | 6171727 |
| P698 | PubMed publication ID | 30345018 |
| P50 | author | Carlos A Mora | Q88252799 |
| Ana C Londoño | Q92454830 | ||
| P2093 | author name string | Carlos A Mora | |
| P2860 | cites work | Stromal cells control soluble material and cellular transport in lymph nodes | Q21131218 |
| Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis | Q24300326 | ||
| Follicular helper T cells: lineage and location | Q24647274 | ||
| The Ins and Outs of B Cells in Multiple Sclerosis | Q26776542 | ||
| Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues | Q26778348 | ||
| Ectopic lymphoid-like structures in infection, cancer and autoimmunity | Q38221815 | ||
| Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management. | Q38690022 | ||
| Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis | Q39119839 | ||
| CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics | Q39527436 | ||
| Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. | Q39808939 | ||
| The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis | Q40414775 | ||
| Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses | Q40427517 | ||
| BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
| Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma. | Q42214758 | ||
| Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients | Q42619341 | ||
| Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial | Q42647640 | ||
| A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
| Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
| CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. | Q44690970 | ||
| Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
| BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. | Q46825742 | ||
| Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation. | Q47110972 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection | Q47603503 | ||
| Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. | Q47935420 | ||
| Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis | Q48162212 | ||
| Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
| Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation. | Q49130159 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. | Q51359685 | ||
| Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. | Q52657141 | ||
| The effects of intrathecal rituximab on biomarkers in multiple sclerosis. | Q52875864 | ||
| Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis. | Q53118262 | ||
| Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. | Q53552315 | ||
| Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis. | Q53624114 | ||
| Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein | Q60455093 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis | Q87460600 | ||
| Tertiary Lymphoid Organs in Central Nervous System Autoimmunity | Q28071379 | ||
| Ectopic Lymphoid Structures: Powerhouse of Autoimmunity | Q28071579 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| In vivo imaging of germinal centres reveals a dynamic open structure | Q33271310 | ||
| The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). | Q33654152 | ||
| Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures | Q33692520 | ||
| Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development | Q33735993 | ||
| Regulated Production of CXCL13 within the Central Nervous System | Q33772300 | ||
| Lymphoid chemokines in the CNS. | Q34020894 | ||
| Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
| Follicular stromal cells and lymphocyte homing to follicles. | Q34067358 | ||
| Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. | Q34083294 | ||
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. | Q34251673 | ||
| Ectopic lymphoid organogenesis: a fast track for autoimmunity | Q34363840 | ||
| Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression | Q34613311 | ||
| Chemokines and neuromodulation | Q34785313 | ||
| CXCL13 antibody for the treatment of autoimmune disorders | Q35086918 | ||
| The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
| B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes | Q35298764 | ||
| Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse | Q35822641 | ||
| Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation | Q36174679 | ||
| B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. | Q36220292 | ||
| Follicular B helper T cells in antibody responses and autoimmunity. | Q36302329 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| Germinal-center organization and cellular dynamics | Q36459345 | ||
| B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation | Q36485715 | ||
| B cell exchange across the blood-brain barrier in multiple sclerosis | Q36498036 | ||
| Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis | Q36639659 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection. | Q37309590 | ||
| Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis | Q37354974 | ||
| Possible role of glial cells in the onset and progression of Lyme neuroborreliosis | Q37356125 | ||
| Intrathecal immune reset in multiple sclerosis: exploring a new concept | Q38177901 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| tertiary lymphoid organ | Q108017266 | ||
| P304 | page(s) | 514 | |
| P577 | publication date | 2018-01-01 | |
| 2018-04-27 | |||
| P1433 | published in | F1000Research | Q27701587 |
| P1476 | title | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis | |
| P478 | volume | 7 |
Search more.